Middle East Pharmaceutical Industries Co (SASE:4016), d/b/a Avalon Pharma, renewed its one-year bank facility agreement amounting to 104 million Saudi riyals with Banque Saudi Fransi.
The Tadawul-listed pharmaceutical company said Thursday the Sharia-compliant facility will be used to fund its working capital.